Cefipime: Difference between revisions
Annhuang04 (talk | contribs) |
Annhuang04 (talk | contribs) |
||
| Line 5: | Line 5: | ||
==Adult Dosing== | ==Adult Dosing== | ||
* 1-2 g IV q12h | |||
===febrile neutropenia=== | |||
* 2g IV q8h | |||
===UTI, mild-mod=== | |||
* 0.5g - 1g q12h x 7-10days | |||
===UTI, severe=== | |||
* 2g IV q12h x 10days | |||
==Pediatric Dosing== | ==Pediatric Dosing== | ||
Revision as of 00:35, 3 September 2015
General
- Type: cephalosporin (4th generation)
- Dosage Forms: IM/IV
- Common Trade Names: Maxipime
Adult Dosing
- 1-2 g IV q12h
febrile neutropenia
- 2g IV q8h
UTI, mild-mod
- 0.5g - 1g q12h x 7-10days
UTI, severe
- 2g IV q12h x 10days
Pediatric Dosing
Special Populations
- Pregnancy:
- Lactation:
- Renal Dosing
- Adult
- Pediatric
- Hepatic Dosing
- Adult
- Pediatric
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Common
Pharmacology
- Half-life:
- Metabolism:
- Excretion:
- Mechanism of Action: